ANCHOR	Amsterdam MASLD-MASH cohort
ANPEP	Alanyl aminopeptidase
AUC	Area under the curve
C7	Complement component 7
CAP	Controlled attenuation parameter
CCDC25	Coiled-coil domain-containing protein 25
CI CRN	Confidence interval Clinical research network
cT1 DIA DTT	Iron-corrected T1 mapping Data-independent acquisition Dithiothreitol
ELF	Enhanced liver fibrosis-test
EV FAIMS	Extracellular vesicle Field asymmetric waveform ion mobility spectrometry
F0	No fibrosis
F1	Mild fibrosis
F2	Significant fibrosis
F3	Advanced fibrosis
F4	Cirrhosis
FIB4	Fibrosis-4 score
GNB1	Guanine nucleotide-binding protein subunit beta-1
GP1BA	Glycoprotein Ib alpha chain
H4C1	Histone H4
HCC	Hepatocellular carcinoma
IGHD	Immunoglobulin heavy constant delta
IQR	Interquartile range
KLHL41 LC-MS	Kelch-like protein 41 Liquid chromatography- mass spectrometer
LSM	Liver stiffness measurement
MASH	Metabolic dysfunction-associated steatohepatitis
MASLD	Metabolic dysfunction-associated steatotic liver disease
MR	Magnetic resonance
MRE	Magnetic resonance elastography
NIT	Non-invasive test
OIT3	Oncoprotein-induced transcript 3
PDFF	Proton density fat fraction
ROC	Receiver operating characteristic
ROI	Region of interest
S1	Mild steatosis
S2	Moderate steatosis
S3 SAF	Advanced steatosis Steatosis, activity and fibrosis
SD	Standard deviation
T2DM	Type 2 diabetes mellitus
VCTE	Vibration-controlled transient elastography